Form 8-K - Current report:
SEC Accession No. 0001193125-23-007281
Filing Date
2023-01-12
Accepted
2023-01-12 17:01:01
Documents
12
Period of Report
2023-01-06
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d446951d8k.htm   iXBRL 8-K 22096
  Complete submission text file 0001193125-23-007281.txt   143421

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA txmd-20230106.xsd EX-101.SCH 2871
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20230106_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20230106_pre.xml EX-101.PRE 11275
6 EXTRACTED XBRL INSTANCE DOCUMENT d446951d8k_htm.xml XML 3347
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 23526504
SIC: 2834 Pharmaceutical Preparations